An EM investigation of skeletal muscle regeneration in cultured explants.

Ph. D. University of Durban-Westville 1995.Abstract available in PDF file

Multi objective optimization of wear behaviour of Aluminum MMCs using Grey-Taguchi method

In recent years, metal matrix composite (MMCs) have been receiving worldwide attention on account of their superior strength-to-weight ratio and stiffness. Among the several classes of composite materials, Aluminium matrix ceramic reinforcement composites have attracted increasing attention due to their unique properties such as better specific strength, specific stiffness, wear resistance, excellent corrosion resistance, high elastic modulus and light weight. The aim of the present investigation is to optimize the dry sliding wear parameters of Aluminum LM25 matrix reinforced with silicon carbide (SiC) (5 wt.%) and Copper (Cu) (3 wt.%) using Taguchi based grey relational analysis. In this work, the composite is prepared using stir casting method. The specimens are prepared according to ASTM standard. Using pin-on-disc apparatus, wear tests are conducted as per Taguchi's L9 orthogonal array and optimum wear parameters are identified with an objective to minimise the wear rate and coefficient of friction based on the grey relational grade. The effect of parameters on the wear rate and coefficient of friction was determined using Analysis of variance (ANOVA). Finally, the experimental results were verified using confirmation tests and the SEM analysis was carried out to study the wear mechanism

An investigation into consumer satisfaction with regard to medical care provided by private medical practitioners in the Durban magisterial district.

Thesis (Ph.D.)-University of Durban-Westville, Durban, 1991.No abstract available

A prospective randomized study of CHOP versus CHOP plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: The International Oncology Study Group NHL1 study

The addition of a brief alpha interferon regimen to each CHOP induction cycle, plus one year of alpha interferon thrice weekly maintenance therapy, has no early effect on response rates or survival in patients with Intermediate or High grade cell NHL